Acamprol 333mg
Upto 15% OFF
The exact working nature of Acamprol cannot be determined. Acamprosate is prescribed mainly for treating alcohol addiction in people who have been addicted to alcohol and...
Read more$0.54 - $0.63
| SKU: | 2 |
|---|---|
| Generic For: | Campral |
| Active Ingredient: | Acamprosate |
| Manufacturer: | Sun Pharma, India |
Buy Acamprol 333mg (Acamprosate) for Addiction Treatment
Acamprol 333mg is a prescription oral tablet containing Acamprosate Calcium 333mg, used in the maintenance of abstinence from alcohol in adult patients with alcohol dependence who have successfully undergone detoxification. Acamprol 333mg is one of three pharmacologically distinct agents approved for alcohol use disorder (AUD), uniquely distinguished by its mechanism of action — restoring the neurochemical balance disrupted by chronic alcohol use — rather than producing aversion or blocking reward pathways. Acamprosate does not treat acute alcohol withdrawal, prevent withdrawal seizures, or produce a deterrent reaction to alcohol; instead, it reduces the craving and protracted abstinence syndrome that drives relapse in detoxified patients, making it an essential component of a comprehensive, evidence-based relapse prevention programme when combined with psychosocial support.
What is Acamprol 333mg?
Acamprol 333mg is an oral enteric-coated tablet containing Acamprosate Calcium 333mg — the standard unit dose in the fixed three-times-daily regimen (two tablets three times daily = 1998mg per day) that constitutes the therapeutic dose for adults weighing more than 60 kg. The 6-tablet pack provides a 3-day supply on the standard protocol, making it suitable for dispensing on short-cycle prescriptions or for initial dose establishment before transitioning to a larger pack. Acamprosate is distinguished from disulfiram and naltrexone — the other two FDA/EMA-approved pharmacological aids for AUD — by its non-aversive, non-opioid mechanism: it directly targets the GABAergic and glutamatergic neurotransmitter imbalance that chronic alcohol exposure produces in the brain, addressing the neurobiological underpinning of post-detoxification craving without altering the subjective response to alcohol if it is consumed.
Manufacturer: Acamprol 333mg is manufactured by Sun Pharma. Acamprol delivers consistent Acamprosate Calcium content with the enteric coating integrity essential for reliable gastrointestinal absorption.
Key Ingredient of Acamprol 333mg
Acamprosate Calcium, the active ingredient in Acamprol, is a synthetic compound structurally analogous to the inhibitory neurotransmitter GABA (gamma-aminobutyric acid) and to the amino acid homotaurine. Chronic heavy alcohol use leads to a fundamental dysregulation of the brain’s principal inhibitory and excitatory neurotransmitter systems: it upregulates and sensitises NMDA (N-methyl-D-aspartate) glutamate receptors and downregulates GABA-A receptor function. When alcohol use ceases, this neuroadaptation is suddenly exposed: without alcohol’s acute suppressant effects on NMDA and potentiation of GABA, the brain experiences a relative hyperglutamatergic, hypoGABAergic state that manifests as anxiety, restlessness, dysphoria, insomnia, and craving — the protracted abstinence syndrome that persists for weeks to months after detoxification and drives a high proportion of relapses.
Acamprosate acts primarily as an NMDA receptor antagonist and a GABA-A receptor modulator, partially correcting this hyperexcitability. By reducing excessive NMDA-mediated glutamate activity and partially restoring GABAergic inhibitory tone, it reduces the neurochemical distress of protracted abstinence — the chronic low-grade dysphoria, craving, and sleep disruption that motivates the detoxified patient to return to drinking. Importantly, Acamprosate does not bind to opioid receptors, does not affect dopaminergic reward pathways, and does not produce CNS depression or impairment at therapeutic doses, making it compatible with psychosocial rehabilitation and daily functioning throughout the treatment period, which is typically one to two years.
Clinical Uses of Acamprosate 333mg
Acamprol 333mg is indicated for the maintenance of abstinence in adult patients with alcohol dependence who are abstinent at the time of initiation and who are participating in a structured treatment programme. Multiple large randomised controlled trials, including the COMBINE study in North America and several European placebo-controlled trials, have demonstrated that Acamprosate significantly increases the proportion of patients remaining continuously abstinent over 6 to 12 months of treatment compared with placebo, with relative risk reductions of approximately 25 to 35% in relapse. Acamprosate is most effective in patients who are highly motivated to remain abstinent at the start of treatment, and its efficacy is further enhanced when combined with counselling, cognitive behavioural therapy, or participation in mutual-aid programmes such as Alcoholics Anonymous.
Acamprosate is the preferred pharmacological adjunct in patients with liver disease, including alcoholic liver disease, because it is not metabolised hepatically; it is excreted unchanged by the kidneys and has no hepatotoxic potential, unlike disulfiram. This makes it the agent of first choice in the common clinical scenario of the alcohol-dependent patient with significant hepatic impairment for whom disulfiram is contraindicated.
Comparing Acamprol 333mg and Campral 333mg: Brand vs Generic Differences
Campral 333mg (Forest Laboratories/Allergan) is the originator branded Acamprosate product used in the phase III clinical trials that established Acamprosate as an approved pharmacotherapy for alcohol dependence. Acamprosate Calcium 333mg is formulated to deliver bioequivalent systemic Acamprosate exposure to the reference product, confirming equivalent NMDA modulation and clinical pharmacodynamics. The evidence for relapse reduction, abstinence maintenance, and safety accumulated with Campral — across multiple national regulatory agency approvals and large-scale clinical programmes — applies directly to Acamprol as a bioequivalent generic formulation.
Related strengths and products: Patients on Acamprol for alcohol dependence may benefit from access to other CNS medications for the co-occurring anxiety and insomnia that characterise the protracted abstinence period; a physician will guide any concurrent prescribing.
Key Benefits of Acamprol 333mg
Acamprol 333mg provides the neurochemically targeted anti-craving mechanism of Acamprosate — the only major pharmacotherapy for alcohol dependence that works by correcting the NMDA/GABA imbalance of protracted abstinence rather than through aversion or opioid blockade. Its hepatically safe profile makes it uniquely suitable for the large proportion of alcohol-dependent patients who present with significant liver damage. Its lack of CNS-depressant, sedative, or dependence-producing effects means that patients can take Acamprol throughout their working day, drive, operate machinery, and engage in the psychosocial therapies that are integral to sustained recovery, without pharmacological impairment.
Usage warnings and precautionary advice for using Acamprosate 333mg
Acamprosate is contraindicated in patients with severe renal impairment (creatinine clearance below 30 ml/min), as the drug is renally excreted and accumulation leads to increased risk of adverse effects. Dose reduction is required in moderate renal impairment (creatinine clearance 30-60 mL/min). Depression and suicidal ideation have been reported during treatment; given the high prevalence of depression in patients with alcohol dependence, baseline mental health assessment and ongoing monitoring are essential. While Acamprosate is not itself addictive and does not produce dependence, patients should understand that it is a pharmacological adjunct to — not a replacement for — sustained behavioural change and professional psychosocial support. Acamprosate does not prevent or treat acute alcohol withdrawal and should not be started until detoxification is complete.
Side effects of Acamprosate 333mg
Acamprol 333mg is generally well tolerated. The most commonly reported side effects involve the gastrointestinal system — diarrhoea is the most frequent adverse effect, occurring in 15-20% of patients in clinical trials; nausea, abdominal discomfort, and flatulence also occur. GI side effects are typically transient and tend to improve with continued treatment over the first few weeks. Pruritus and skin rash have been reported. Anxiety, insomnia, and depression are difficult to distinguish from background protracted abstinence symptoms in the patient population, but have been reported as adverse events in clinical trials. Acamprosate does not cause liver toxicity, sedation, or impairment of cognitive or psychomotor function at therapeutic doses — a significant tolerability advantage over both disulfiram and some other CNS agents used in AUD.
Benefits of Buying Acamprol 333mg Online from AllDayChemist
AllDayChemist provides Acamprol 333mg at competitive prices with reliable home delivery, ensuring that patients committed to alcohol abstinence can maintain a consistent, uninterrupted supply of their relapse prevention medication without the added burden of repeated pharmacy visits. Consistency of treatment is directly linked to better abstinence outcomes in alcohol dependence management.
Proper dosage and usage guide of Acamprosate Calcium 333mg
The standard dose of Acamprol for adults weighing more than 60 kg is two tablets (666mg) three times daily — taken at breakfast, midday, and evening. For adults weighing less than 60 kg, the dose is reduced to 4 tablets per day (1 in the morning and 2 at midday and evening). Tablets should be swallowed whole with water, with or without food. Addiction Treatment should be initiated as soon as possible after detoxification and continued for one to two years; do not stop Acamprol if there is a brief relapse — continue treatment and maintain engagement with the support programme. Missing doses should be caught up only if it is close to the scheduled time; do not double up. Renal function should be assessed before starting, as dose reduction is required in moderate renal impairment, and Acamprosate is contraindicated in severe renal impairment. Store at room temperature below 25°C.
What is Acamprol 333mg prescribed for, and which patients benefit most from it?
Acamprol 333mg contains acamprosate and helps people stay alcohol-free after they stop drinking. Doctors prescribe it to reduce cravings and make it easier to maintain sobriety. It works best for patients who have already quit alcohol and want support to stay sober long-term. This medicine is not a cure, but a tool that supports your recovery journey alongside counseling and support groups.
How does Acamprosate work inside the body?
Acamprosate helps restore balance to chemicals in your brain that become unbalanced after long-term alcohol use. When you stop drinking, your brain struggles to adjust, which causes cravings and discomfort. Acamprosate calms this process, reducing the urge to drink and making withdrawal feelings less intense. It does not make you feel high or create dependence.
Food and alcohol: should I take this tablet with food, and is alcohol safe during treatment?
You can take Acamprol 333mg with or without food. Food does not affect how well it works. However, you must not drink alcohol while taking this medicine. Combining alcohol with acamprosate defeats the purpose of treatment and may cause harmful effects. If you slip and drink, tell your doctor immediately rather than stopping treatment.
How should I store these tablets at home to keep them safe and effective?
Store Acamprol 333mg in a cool, dry place away from heat and direct sunlight. Keep the tablets in their original container with the lid tightly closed. Do not store them in the bathroom where moisture can damage them. Keep them out of reach of children and pets. Check the expiration date before taking any tablet.
What should I do if I accidentally take more tablets than prescribed?
If you take more Acamprol 333mg than prescribed, contact your poison control center or emergency services immediately. Tell them exactly how many tablets you took. Do not wait for symptoms to appear. Keep the tablet bottle with you so medical staff can see what you took. It is better to seek help early than to wait.
How soon does Acamprol 333mg start working, and what changes should I expect?
Acamprol 333mg begins working within days, but full effects develop over weeks. Most people notice reduced cravings within one to two weeks of starting treatment. Greater improvement comes after four to eight weeks of consistent use. Patience is important because your brain needs time to heal. Continue taking it exactly as prescribed, even if you do not feel changes immediately.
What are the most important safety warnings I need to know before taking Acamprol 333mg?
Do not take Acamprol 333mg if you are allergic to acamprosate. Tell your doctor if you have kidney problems, as this medicine is filtered by your kidneys. Avoid alcohol completely while taking this tablet. Some people experience dizziness or low mood, so be careful when driving or operating machinery. Report any new or worsening symptoms to your doctor right away.
How does Acamprol 333mg compare to the brand, Campral and other treatments for Alcohol & Drug Treatment?
Acamprol 333mg contains the same active ingredient as Campral brand and works identically. The main difference is cost, as Acamprol is more affordable. Other alcohol-recovery medicines like naltrexone work by different methods and suit different patients. Your doctor will choose the right medicine based on your health history, kidney function, and personal needs.
How long do I need to take Acamprol 333mg, and is it safe to stop suddenly?
Most people take Acamprol 333mg for one year after quitting alcohol, though some continue longer. Do not stop taking it suddenly without talking to your doctor first. Stopping abruptly may increase cravings and your risk of drinking again. Your doctor will discuss when it is safe to reduce or stop the medicine. Always follow their guidance on your treatment timeline.
How does Acamprol 333mg compare to naltrexone, and when would a doctor choose one over the other?
Acamprol 333mg and naltrexone both help prevent alcohol relapse but work differently. Acamprol reduces brain chemistry imbalance and cravings, while naltrexone blocks alcohol's rewarding effects. Doctors choose acamprol for patients with kidney problems or those who prefer a gentler approach. Naltrexone suits patients with liver problems or those wanting stronger blocking effects. Both are effective; the choice depends on your individual health.
What should I tell my doctor or pharmacist before I start taking Acamprol 333mg?
Tell your doctor about all your health conditions, especially kidney disease, depression, or suicidal thoughts. List every medicine you take, including over-the-counter drugs and supplements. Mention any allergies you have. Be honest about your drinking history and any previous addiction treatments. Discuss your mental health and any family history of depression. This information helps your doctor ensure Acamprol 333mg is safe and right for you.
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Login
Sign Up
Leading Online Pharmacy
100% Genuine
Products
& OTC Products
Forgot Password ?